Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP140563.RAJ9wWCXeBHs-oCQQ13Nir2zJysWt9yCphuZjaEyNpBUA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP140563.RAJ9wWCXeBHs-oCQQ13Nir2zJysWt9yCphuZjaEyNpBUA130_assertion type Assertion NP140563.RAJ9wWCXeBHs-oCQQ13Nir2zJysWt9yCphuZjaEyNpBUA130_head.
- NP140563.RAJ9wWCXeBHs-oCQQ13Nir2zJysWt9yCphuZjaEyNpBUA130_assertion description "[Approximately 50% of glioblastomas (GBMs) are characterized by overexpression of the epidermal growth factor receptor (EGFR) and EGFR gene amplification.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP140563.RAJ9wWCXeBHs-oCQQ13Nir2zJysWt9yCphuZjaEyNpBUA130_provenance.
- NP140563.RAJ9wWCXeBHs-oCQQ13Nir2zJysWt9yCphuZjaEyNpBUA130_assertion evidence source_evidence_literature NP140563.RAJ9wWCXeBHs-oCQQ13Nir2zJysWt9yCphuZjaEyNpBUA130_provenance.
- NP140563.RAJ9wWCXeBHs-oCQQ13Nir2zJysWt9yCphuZjaEyNpBUA130_assertion SIO_000772 19204207 NP140563.RAJ9wWCXeBHs-oCQQ13Nir2zJysWt9yCphuZjaEyNpBUA130_provenance.
- NP140563.RAJ9wWCXeBHs-oCQQ13Nir2zJysWt9yCphuZjaEyNpBUA130_assertion wasDerivedFrom gad-20150221 NP140563.RAJ9wWCXeBHs-oCQQ13Nir2zJysWt9yCphuZjaEyNpBUA130_provenance.
- NP140563.RAJ9wWCXeBHs-oCQQ13Nir2zJysWt9yCphuZjaEyNpBUA130_assertion wasGeneratedBy ECO_0000203 NP140563.RAJ9wWCXeBHs-oCQQ13Nir2zJysWt9yCphuZjaEyNpBUA130_provenance.